Suzanne Schindler

Has grant

Associate Professor

Washington University in St. Louis

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Suzanne Schindler is an Associate Professor at Washington University in St Louis, USA. Her research focuses on Alzheimer's disease, particularly in the areas of biomarker development, cognitive decline prediction, and dementia heterogeneity. She has contributed to recent studies examining the efficacy of blood tests for Alzheimer's pathology and the role of various biomarkers in diagnostic applications.

Recent Grants

Grant: Close

Staging Alzheimer disease with blood-based biomarkers

Open Date: 2021-02-15

Close Date: 2026-01-31

Grant: Close

STAGING PRECLINICAL AD WITH CSF BIOMARKERS

Open Date: 2017-07-15

Close Date: 2021-04-30

Grant: Close

AGE-RELATED BIOMARKET CHANGES IN CEREBROSPINAL FLUID

Open Date: 2015-09-01

Close Date: 2017-05-31

Grant: Close

AGE-RELATED BIOMARKET CHANGES IN CEREBROSPINAL FLUID

Open Date: 2015-09-01

Close Date: 2018-05-31

Articles (17)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

Associate Professor

Washington University in St. Louis

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Suzanne Schindler

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (17)

Baseline and longitudinal changes in cortical thickness and hippocampal volume predict cognitive decline

Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease

Biomarker-based staging of Alzheimer disease: rationale and clinical applications

Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests

Investigating White Matter Neuroinflammation in Alzheimer Disease Using Diffusion-Based Neuroinflammation Imaging

Examining heterogeneity in dementia using data-driven unsupervised clustering of cognitive profiles

Head‐to‐head comparison of leading blood tests for Alzheimer's disease pathology

The role of cerebrospinal fluid and other biomarker modalities in the Alzheimer’s disease diagnostic revolution

Using Alzheimer's disease blood tests to accelerate clinical trial enrollment

Comparison of plasma and CSF biomarkers in predicting cognitive decline

A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia.

The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All.

Comorbidities confound Alzheimer's blood tests.

ANA Investigates: The Future of Biomarkers in Alzheimer Disease.

Fluid Biomarkers in Dementia Diagnosis.

Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light.

Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease.

Collaborators (10)

Thomas Karikari

Barton Hamilton

Melissa Murray

Brian Gordon

Philip Payne

Sarah Hartz

Qing Wang

Nelly Joseph-Mathurin

Andrew Aschenbrenner

Jason Hassenstab

Make your next move.